Analysts predict that Imax Corporation (NYSE:IMAX) will report $84.62 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for Imax Corporation’s earnings, with estimates ranging from $81.40 million to $89.74 million. Imax Corporation posted sales of $86.55 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 2.2%. The company is expected to issue its next quarterly earnings report before the market opens on Thursday, October 26th.

On average, analysts expect that Imax Corporation will report full-year sales of $84.62 million for the current year, with estimates ranging from $350.80 million to $371.63 million. For the next financial year, analysts forecast that the business will report sales of $416.33 million per share, with estimates ranging from $408.70 million to $426.92 million. Zacks’ sales calculations are an average based on a survey of research firms that cover Imax Corporation.

Imax Corporation (NYSE:IMAX) last posted its earnings results on Wednesday, July 26th. The company reported $0.15 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.17. The company had revenue of $87.76 million during the quarter, compared to analyst estimates of $89.26 million. Imax Corporation had a return on equity of 2.39% and a net margin of 2.81%. The business’s revenue was down 4.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.18 earnings per share.

Several research analysts recently issued reports on the stock. B. Riley reissued a “buy” rating and issued a $35.00 price target on shares of Imax Corporation in a research report on Thursday, July 27th. BidaskClub lowered shares of Imax Corporation from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. Canaccord Genuity set a $33.00 price target on shares of Imax Corporation and gave the stock a “buy” rating in a research report on Friday, August 18th. Barrington Research lowered shares of Imax Corporation from an “outperform” rating to a “market perform” rating in a research report on Wednesday, July 12th. Finally, Credit Suisse Group dropped their price target on shares of Imax Corporation from $26.00 to $25.00 and set a “neutral” rating for the company in a research report on Thursday, September 28th. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $32.00.

Imax Corporation (NYSE:IMAX) opened at 21.30 on Friday. The company has a market capitalization of $1.38 billion, a price-to-earnings ratio of 143.92 and a beta of 1.00. The stock’s 50 day moving average price is $21.56 and its 200 day moving average price is $23.98. Imax Corporation has a 12-month low of $17.58 and a 12-month high of $35.30.

In other news, CFO Patrick Mcclymont sold 1,760 shares of the stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $20.50, for a total transaction of $36,080.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Greg Foster sold 9,417 shares of the stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $19.55, for a total transaction of $184,102.35. Following the sale, the chief executive officer now directly owns 67,018 shares in the company, valued at $1,310,201.90. The disclosure for this sale can be found here. Company insiders own 18.90% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Imax Corporation by 13.0% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,522 shares of the company’s stock valued at $181,000 after purchasing an additional 748 shares during the last quarter. BNP Paribas Arbitrage SA grew its stake in shares of Imax Corporation by 1,151.0% during the second quarter. BNP Paribas Arbitrage SA now owns 6,818 shares of the company’s stock valued at $150,000 after purchasing an additional 6,273 shares during the last quarter. Seven Eight Capital LP grew its stake in shares of Imax Corporation by 1,115.7% during the second quarter. Seven Eight Capital LP now owns 7,294 shares of the company’s stock valued at $160,000 after purchasing an additional 6,694 shares during the last quarter. Aperio Group LLC bought a new stake in shares of Imax Corporation during the second quarter valued at approximately $205,000. Finally, M&T Bank Corp bought a new stake in shares of Imax Corporation during the second quarter valued at approximately $230,000. 83.36% of the stock is currently owned by institutional investors and hedge funds.

WARNING: This article was originally published by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/10/22/84-62-million-in-sales-expected-for-imax-corporation-imax-this-quarter.html.

Imax Corporation Company Profile

IMAX Corporation is an entertainment technology company. The Company operates through seven segments: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production, and other. The IMAX systems segment designs, manufactures, sells or leases IMAX theater projection system equipment.

Get a free copy of the Zacks research report on Imax Corporation (IMAX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Imax Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imax Corporation and related companies with MarketBeat.com's FREE daily email newsletter.